Evaluation of current and upcoming therapies in oral mucositis prevention

A Deletion Polymorphism in Glutathione-S-Transferase Mu (GSTM1) and/or Theta (GSTT1) Is Associated with an Increased Risk of Toxicity after Autologous Blood and Marrow Transplantation

(2010) Theresa Hahn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma

(2010) Hyun-Jung Cho et al.   CANCER GENETICS AND CYTOGENETICS

Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck Cancer

(2010) D. A. Hamstra et al.   CLINICAL CANCER RESEARCH

Glutathione S-transferases: an overview in cancer research

(2010) Giuliano Di Pietro et al.   Expert Opinion on Drug Metabolism & Toxicology

Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer

(2010) Tomoko Watanabe et al.   INTERNATIONAL JOURNAL OF CANCER

Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations

(2009) D. E. Peterson et al.   ANNALS OF ONCOLOGY

Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer

(2009) Hong Gyun Wu et al.   CANCER

Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?

(2009) Noor Al-Dasooqi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis

(2009) Y.-L. Chung et al.   CARCINOGENESIS

Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial

(2009) A. KAZEMIAN et al.   EUROPEAN JOURNAL OF CANCER CARE

Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation

(2009) Ana Chor et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Recombinant Human Intestinal Trefoil Factor Oral Spray for Prevention of Oral Mucositis in Patients With Colorectal Cancer Who Are Receiving Fluorouracil-Based Chemotherapy

(2009) Douglas E. Peterson et al.   JOURNAL OF CLINICAL ONCOLOGY

Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity

(2009) Nielka P. van Erp et al.   JOURNAL OF CLINICAL ONCOLOGY

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy

(2009) Barbara A. Murphy et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: Comparison between low and high/low power lasers

(2009) Alyne Simões et al.   LASERS IN SURGERY AND MEDICINE

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

(2009) Stephen T. Sonis   ORAL ONCOLOGY

R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/ -catenin pathway

(2009) J. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tipping the balance: modulating the Wnt pathway for tissue repair

(2009) Jingsong Zhao et al.   TRENDS IN BIOTECHNOLOGY

Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial

(2008) A Hunter et al.   BONE MARROW TRANSPLANTATION

Febrile mucositis in haematopoietic SCT recipients

(2008) W J F M van der Velden et al.   BONE MARROW TRANSPLANTATION

Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis

(2008) Narissa J. Nonzee et al.   CANCER

The trefoil factor family – small peptides with multiple functionalities

(2008) S. Kjellev   CELLULAR AND MOLECULAR LIFE SCIENCES

Evaluation of D-Methionine as a Novel Oral Radiation Protector for Prevention of Mucositis

(2008) S. B. Vuyyuri et al.   CLINICAL CANCER RESEARCH

Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine

(2008) Loren K Mell et al.   Expert Opinion on Drug Metabolism & Toxicology

Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation

(2008) Takehiko Mori et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group

(2008) Nicole Blijlevens et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma

(2008) David M. Brizel et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

(2008) Matthias Schwab et al.   JOURNAL OF CLINICAL ONCOLOGY

Bioactive sphingolipids: metabolism and function

(2008) Nana Bartke et al.   JOURNAL OF LIPID RESEARCH

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

(2008) Robert J Motzer et al.   LANCET

Effects of Palifermin on Antitumor Activity of Chemotherapeutic and Biological Agents in Human Head and Neck and Colorectal Carcinoma Xenograft Models

(2008) R. Brake et al.   MOLECULAR CANCER RESEARCH

Radiation Treatment Breaks and Ulcerative Mucositis in Head and Neck Cancer

(2008) G. Russo et al.   ONCOLOGIST

Silencing of Keratinocyte Growth Factor Receptor Restores 5-Fluorouracil and Tamoxifen Efficacy on Responsive Cancer Cells

(2008) Sabrina Rotolo et al.   PLoS One

The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies

(2008) M. T. Genot-Klastersky et al.   SUPPORTIVE CARE IN CANCER

Tumor necrosis factor-α induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-κB in A549 cells

(2008) C LIN et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY